Copenhagen: More European nations have fully or partially suspended the use of the British company AstraZeneca-developed COVID-19 vaccine after reports of several suspected deaths from clotting after inoculation.
The Danish Health Authority announced in a statement on Thursday that the use of the AstraZeneca-developed vaccine has been banned in Denmark for 14 days owing to apprehensions of serious adverse reactions.
The authority added that the move was based on “concerns raised by the drug authorities” and “a precautionary principle”, reported Xinhua news agency.
The ban came following several reports of blood clots after vaccinations and the death of a 60-year-old woman. The woman received a shot and then died after developing a blood clot, Danish news agency Ritzau said.
In a statement on Thursday, the European Medicines Agency (EMA) described the Danish Health Authority’s move as a “precautionary measure” but stressed there was “currently no indication that vaccination has caused these conditions”.
Austria, Italy, Bulgaria, Romania, Estonia, Lithuania, Luxembourg, Latvia and non-European Union (EU) countries Norway and Iceland have also suspended the use of the vaccine as a precautionary measure following similar reports of blood clots. The European drug regulators are still probing into the matter.
ALSO READ: AstraZeneca Vaccine: Clots, Blood Thinners & All The Concerns Explained
